RecruitingPhase 3NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Manhasset, NY · New York, NY · Stony Brook, NY · +145 more sites